Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Lipocine Inc. (LPCN)

0.53   -0.028 (-4.93%) 02-26 16:00
Open: 0.56 Pre. Close: 0.5575
High: 0.5643 Low: 0.52
Volume: 2,660,182 Market Cap: 19M
Lipocine Inc is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men's and women's health.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.561 - 0.564 0.564 - 0.568
Low: 0.512 - 0.515 0.515 - 0.519
Close: 0.524 - 0.529 0.529 - 0.536

Technical analysis

as of: 2020-02-26 4:30:19 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 0.74     One year: 0.90
Support: Support1: 0.42    Support2: 0.35
Resistance: Resistance1: 0.64    Resistance2: 0.77
Pivot: 0.49
Moving Average: MA(5): 0.56     MA(20): 0.48
MA(100): 1.09     MA(250): 1.70
MACD: MACD(12,26): 0.02     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 56.82     %D(3): 62.09
RSI: RSI(14): 52.64
52-week: High: 3.45  Low: 0.32  Change(%): -69.5
Average Vol(K): 3-Month: 139799  10-Days: 274259

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
LPCN has closed below upper band by 37.8%. Bollinger Bands are 56.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to LPCN's normal range. The bands have been in this narrow range for 58 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2020-02-25
Lipocine Announces $6 Million Registered Direct Offering Priced At-The-Market
SALT LAKE CITY, Feb. 25, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ:LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that it has entered into securities purchase agreements with certain institutional investors providing for…

2020-02-24
Lipocine Announces Regulatory Path Forward for TLANDO™ Resubmission
SALT LAKE CITY, Feb. 24, 2020 /PRNewswire/ -- Lipocine Inc. (LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the results of its Post Action meeting with the U.S. Food and Drug Administration ("FDA') regarding its New Drug…

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 35.85
Shares Float (M) 23.99
% Held by Insiders 6.06
% Held by Institutions 26.01
Shares Short (K) 683
Shares Short P. Month (K)

Stock Financials

EPS -0.548
Book Value (p.s.) 0.300
PEG Ratio
Profit Margin
Operating Margin -7650.71
Return on Assets (ttm) -39.4
Return on Equity (ttm) -134.3
Qtrly Rev. Growth
Gross Profit (p.s.) -0.118
Sales Per Share
EBITDA (p.s.) -0.352
Qtrly Earnings Growth
Operating Cash Flow (M) -10.59
Levered Free Cash Flow (M) -6.08

Stock Valuations

P/E -0.97
P/E Growth Ratio -0.05
P/BV 1.77
P/S 52.99
P/CF -1.79

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2013-07-24
Last Split Ratio 0.01
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.